Ticker > Company >

Acutaas Chemicals share price

Acutaas Chemicals Ltd.

NSE: ACUTAAS BSE: 543349 SECTOR: Pharmaceuticals & Drugs  2.34 L   434   87

1470.70
+13.00 (0.89%)
BSE: 11 Sep 04:01 PM

Price Summary

Today's High

₹ 1487.9

Today's Low

₹ 1463.75

52 Week High

₹ 1529.1

52 Week Low

₹ 705.58

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsAverage
The company could improve upon its asset employment.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

12040.46 Cr.

Enterprise Value

11806.09 Cr.

No. of Shares

8.19 Cr.

P/E

63.21

P/B

8.88

Face Value

₹ 5

Div. Yield

0.05 %

Book Value (TTM)

₹  165.65

CASH

240.72 Cr.

DEBT

6.35 Cr.

Promoter Holding

32.66 %

EPS (TTM)

₹  23.27

Sales Growth

43.96%

ROE

16.08 %

ROCE

19.99%

Profit Growth

265.22 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year43.96%
3 Year23.92%
5 Year32.8%

Profit Growth

1 Year265.22%
3 Year30.4%
5 Year42.17%

ROE%

1 Year16.08%
3 Year12.7%
5 Year19.78%

ROCE %

1 Year19.99%
3 Year16.96%
5 Year21.56%

Debt/Equity

0.0048

Price to Cash Flow

103.86

Interest Cover Ratio

37.4625

CFO/PAT (5 Yr. Avg.)

0.702336305075961

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 32.66 0.00
Mar 2025 35.96 0.00
Dec 2024 35.96 0.00
Sep 2024 35.97 0.00
Jun 2024 35.98 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 30.4046474252034% for the Past 3 years.
  • The company has shown a good revenue growth of 23.9218588280531% for the Past 3 years.
  • The company has significantly decreased its debt by 196.3807 Cr.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 37.4625.
  • The Company has been maintaining an effective average operating margins of 20.41208% in the last 5 years.
  • Company’s PEG ratio is 0.979648588515599.
  • The company has an efficient Cash Conversion Cycle of 56.3583 days.
  • Company has a healthy liquidity position with current ratio of 3.8752.

 Limitations

  • The company is trading at a high PE of 63.21.
  • The company is trading at a high EV/EBITDA of 41.8223.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 171.14 243.59 270.94 304.16 205.97
Total Expenditure 144.84 195.46 204.29 220.1 154.98
Operating Profit 26.3 48.13 66.66 84.06 50.99
Other Income 1.9 8.58 2.17 5.69 16.02
Interest 4.37 0.49 0.61 0.38 0.62
Depreciation 5.62 6.2 5.67 6.56 7.46
Exceptional Items 0 0 0 0 0
Profit Before Tax 18.2 50.02 62.54 82.81 58.93
Tax 4.49 12.34 17.24 19.97 14.28
Profit After Tax 13.72 37.68 45.3 62.85 44.65
Adjusted EPS (Rs) 1.68 4.6 5.53 3.84 5.45

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales 340.61 520.14 616.73 687.58 989.83
Total Expenditure 260.41 414.96 494.07 579.92 764.69
Operating Profit 80.2 105.18 122.66 107.67 225.14
Other Income 1.33 2.76 4.32 13.79 18.34
Interest 5.62 6.41 2.41 5.89 5.86
Depreciation 4.19 10.08 12.34 14.69 24.05
Exceptional Items 0 0 0 -31.75 0
Profit Before Tax 71.73 91.45 112.22 69.11 213.58
Tax 17.73 19.5 28.88 25.42 54.03
Net Profit 54 71.95 83.34 43.68 159.55
Adjusted EPS (Rs.) 2.86 9.87 11.44 5.92 9.74

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity and Liabilities
Share Capital 31.5 36.44 36.44 36.88 40.93
Total Reserves 132.45 481.57 550.35 638.23 1270.66
Borrowings 72.64 0.59 0.38 113.64 0
Other N/C liabilities 7.65 6.7 9.51 14.65 27.32
Current liabilities 166.04 129.31 162.78 267.84 199.04
Total Liabilities 410.29 654.61 759.46 1071.25 1537.95
Assets
Net Block 160.61 177.88 222.09 357.06 499.23
Capital WIP 0.2 1.89 25.52 125.42 130.28
Intangible WIP 0 1.07 4.28 0 0
Investments 33.24 33.4 33.45 67.73 69.8
Loans & Advances 1.84 7.78 17.19 51.67 58.86
Other N/C Assets 1.25 5.87 2.21 1.56 8.47
Current Assets 213.14 426.71 454.71 467.81 771.31
Total Assets 410.29 654.61 759.46 1071.25 1537.95
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Profit from operations 71.73 91.45 112.22 69.11 213.58
Adjustment 8.87 12.36 11.19 41.84 14.6
Changes in Assets & Liabilities -39.5 -90.68 -43.23 6.02 -68.54
Tax Paid -14.18 -22.81 -24.45 -16.12 -43.72
Operating Cash Flow 26.92 -9.69 55.73 100.85 115.93
Investing Cash Flow -100.74 -122.47 -20.47 -337.32 -234.37
Financing Cash Flow 72.11 140.26 -14.44 235.48 273.56
Net Cash Flow -1.72 8.1 20.82 -0.99 155.12

Corporate Actions

Investors Details

PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
promoters 35.98 35.97 35.96 35.96 32.66
nareshkumar ramjibhai pat... 10.46 10.45 19.34 19.34 17.69
vaghasia chetankumar chha... 7.78 7.78 16.62 16.62 14.97
bhanuben chhaganbhai vagh... 0.84 0.84 - - -
chhagan ramjibhai vaghasi... 0.83 0.83 - - -
parulben vaghasia 7.18 7.18 - - -
sheetalben n patel 8.89 8.89 - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 64.02 64.03 64.04 64.04 67.34
aditya birla sun life ins... - - - - 1.63
ashish kacholia 1.85 1.84 1.84 1.72 1.17
ashoka whiteoak icav - as... 1.47 1.47 1.47 1.29 1.17
axis max life insurance l... - - - 2.60 2.59
bank of india small cap f... 1.34 1.71 1.60 1.58 1.59
dhwani girishkumar chovat... 3.35 3.35 3.35 3.35 3.35
government of singapore 1.14 2.05 1.89 1.89 1.33
government pension fund g... 2.67 2.67 2.67 3.35 3.54
kotak mahindra trustee co... 1.32 - - - 3.78
llp 0.26 0.24 0.19 0.20 0.19
sbi large & midcap fund - 4.32 4.49 4.23 4.06
tata mutual fund - tata e... - - 1.03 - 1.14
union small cap fund - - - - 1.02
uti small cap fund - - - - 1.15
vanaja sundar iyer 1.22 1.16 1.16 1.16 1.16
vanguard total internatio... - - - - 1.09
malabar india fund limite... 2.31 1.81 1.35 1.07 -
quant mutual fund - quant... - 1.77 1.96 1.92 -
goldman sachs funds - gol... - 1.02 1.02 - -
max life insurance compan... 2.44 3.67 3.65 - -
uti - healthcare fund 1.04 1.01 - - -
plutus wealth management ... 4.06 - - - -
sbi healthcare opportunit... 1.28 - - - -

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
Research IDBI Capital
Research HDFC Securities
Research Report By:
Research IDBI Capital
Research IDBI Capital
Research IDBI Capital
Research BP Wealth
Research BOB Capital Market

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY24
Concall Q4FY22
Concall Q3FY25
Concall Q3FY24
Concall Q3FY22
Concall Q2FY24
Concall Q1FY24
Concall Q1FY24
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY24
Presentation Q4FY22
Presentation Q3FY24
Presentation Q3FY22
Presentation Q2FY22

Company News

Acutaas Chemicals Stock Price Analysis and Quick Research Report. Is Acutaas Chemicals an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Acutaas Chemicals. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Acutaas Chemicals has a PE ratio of 63.3026734290381 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Acutaas Chemicals has ROA of 12.2295% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Acutaas Chemicals has a Current ratio of 3.8752.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Acutaas Chemicals has a ROE of 16.0809%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Acutaas Chemicals has a Debt to Equity ratio of 0.0048 which means that the company has low proportion of debt in its capital.

  • Sales growth: Acutaas Chemicals has reported revenue growth of 43.9586% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Acutaas Chemicals for the current financial year is 22.7454465624863%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Acutaas Chemicals is Rs 1.5 and the yield is 0.0508%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Acutaas Chemicals is Rs 23.266. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Acutaas Chemicals in Ticker for free. Also, one can get the intrinsic value of Acutaas Chemicals by using Valuation Calculators, which are available with a Finology ONE subscription. 

Acutaas Chemicals FAQs

Q1. What is Acutaas Chemicals share price today?
Ans: The current share price of Acutaas Chemicals is Rs 1472.8.

Q2. What is the market capitalisation of Acutaas Chemicals?
Ans: Acutaas Chemicals has a market capitalisation of Rs 12057.65483216 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Acutaas Chemicals?
Ans: The PE ratio of Acutaas Chemicals is 63.3026734290381 and the P/B ratio of Acutaas Chemicals is 8.891201706763, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Acutaas Chemicals share?
Ans: The 52-week high share price of Acutaas Chemicals is Rs 1530.3, and the 52-week low share price of Acutaas Chemicals is Rs 704.1.

Q5. Does Acutaas Chemicals pay dividends?
Ans: Currently, Acutaas Chemicals pays dividends. Dividend yield of Acutaas Chemicals is around 0.0508%.

Q6. What are the face value and book value of Acutaas Chemicals shares?
Ans: The face value of Acutaas Chemicals shares is Rs 5, while the book value per share of Acutaas Chemicals is around Rs 165.6469. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Acutaas Chemicals?
Ans: Acutaas Chemicals has a total debt of Rs 6.349 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Acutaas Chemicals?
Ans: The ROE of Acutaas Chemicals is 16.0809% and ROCE of Acutaas Chemicals is 19.9867%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Acutaas Chemicals a good buy for the long term?
Ans: The Acutaas Chemicals long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Acutaas Chemicals undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Acutaas Chemicals appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Acutaas Chemicals’s financials?
Ans: You can review Acutaas Chemicals’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Acutaas Chemicals
X